NEW YORK (GenomeWeb News) – Abbott Laboratories said yesterday that it has received the CE Mark for a PCR-based test that can detect a new variant strain of Chlamydia trachomatis that has been found in one in five chlamydia cases in Sweden.
 
The assay, which may now be sold for clinical diagnostic use throughout the European Union, is run on Abbott’s automated m2000 real-time PCR system. Abbott said that the assay would be offered in Europe as part of its alliance with Celera.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.